Cancer firm wants to enter Europe and USA with new product – DKK 19 million received for launch
Nanovi has received DKK 19 million (USD 2.8 million) to bring its product to market, first in Europe and then in the USA. The company expects to expand the market for cancer markers, which today is worth more than USD 100 million.
The Danish company Nanovi, that started at DTU and develops growth markers for cancer treatment, has taken a step closer to launching the firm’s first product for use on humans.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
